Liver, Gallbladder, Pancreas Center
(Hepatobiliary Malignancies)

For questions or an appointment, phone: 315 464-1800 or
Upstate Connect: 315 464-8668

Patients with hepatobiliary tumors include patients with primary hepatocellular carcinoma, metastatic cancer to the liver, pancreatic cancer and biliary or gall bladder cancer. The Liver, Gallbladder, Pancreas Center was established in June 1994 and provides for the comprehensive and efficient evaluation of patients with both malignant and nonmalignant diseases involving these organs.

Medical Oncology has been an active member in this multidisciplinary team. Patients with suspected or diagnosed tumors related to these organ systems can often be evaluated by general surgeons, gastroenterologists, medical oncologists, radiation oncologists and interventional radiologists quickly. Each member of this team brings a special expertise. The coordinated efforts allow for a well thought-out and streamlined diagnostic and treatment plan.

Specifically, our colleagues in interventional radiology are now able to provide "directed therapy." Hepatic artery chemoembolization is a viable option for both hepatocellular carcinoma as well as metastatic disease to the liver. Our surgical colleagues are able to place hepatic artery infusion pumps into the abdominal wall allowing for continuous home delivery of chemotherapy directly to the liver. Radiation oncologists can participate in intraoperative radiotherapy when necessary. As a group, we are involved in evaluating and carrying out protocols from our own center as well as those from national cooperative groups such as cancer and Leukemia Group B. We are combining efforts with Brown University Cancer Center Clinical Oncology Group of Rhode Island in investigating new chemotherapy and radiotherapy strategies for diseases of these organ systems.